NanoSyrinx is a cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector.
| Website | http://www.nanosyrinx.com |
| Revenue | $1 million |
| Employees | 30 (20 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology, Drug Delivery, Pharmaceuticals, Healthcare |
| Keywords | Targeted Drug Delivery, Drug Delivery, Drug Delivery Systems, Advanced Drug Delivery, Synthetic Biology, Controlled Release, Novel Drug Delivery, Nanomedicine, Precision Medicine, Next Generation Therapeutics, Nanotechnology, Biotechnology, Drug Development, Innovative Therapies, Therapeutics, Biopharma, Pharmaceutical, Biosensors, Pharmaceutical Technology |
| Competitors | CureVac, Wave Life Sciences, Scribetx, Geno, Arrakis Therapeutics, Ribometrix Inc., Aptamer Group, Treventis Corporation, Ribon Therapeutics, Disarm Therapeutics +37 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies |
Looking for a particular NanoSyrinx employee's phone or email?
The NanoSyrinx annual revenue was $1 million in 2026.
Tom Farrell is the CEO of NanoSyrinx.
20 people are employed at NanoSyrinx.
The NAICS codes for NanoSyrinx are [5417, 541, 54, 541713, 54171].
The SIC codes for NanoSyrinx are [873, 87].